MSP Recovery (MSPR) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Offering details and pricing
Registration covers up to 9,956,415 shares of Class A common stock for resale by selling shareholders, including shares issuable upon exercise of warrants and shares issued for services and debt satisfaction.
Shares include up to 5,000,000 issuable upon exercise of VRM Warrants, 2,500,000 upon exercise of VRP Warrants, and 1,956,415 issued to a technology partner under a services agreement.
Registration is for a delayed or continuous offering under Rule 415, allowing shares to be sold from time to time after effectiveness.
Management team and governance
Chief Executive Officer and Chairman is John H. Ruiz; Francisco Rivas-Vásquez serves as Chief Financial Officer.
Board includes directors Frank C. Quesada, Ophir Sternberg, Beatriz Assapimonwait, Michael Arrigo, Thomas W. Hawkins, and Roger Meltzer.
Underwriters and syndicate
Baker & McKenzie LLP acts as special securities counsel and provided the legal opinion for the registration.
Latest events from MSP Recovery
- Annual meeting to vote on director re-election and auditor ratification, with strong governance.MSPR
Proxy Filing2 Dec 2025 - Approval sought for reverse stock split and major share issuance to support Nasdaq compliance.MSPR
Proxy Filing2 Dec 2025 - Key votes on a reverse stock split and major share issuance to VRM to ensure Nasdaq compliance.MSPR
Proxy Filing2 Dec 2025 - Vote on reverse split and VRM share issuance may reshape ownership and Nasdaq compliance.MSPR
Proxy Filing2 Dec 2025 - Shareholders are advised to await a corrected proxy statement with updated meeting details.MSPR
Proxy Filing2 Dec 2025 - Registering nearly 10M shares for resale amid high losses, debt, and going concern risks.MSPR
Registration Filing29 Nov 2025 - Healthcare claims recovery firm registers 8.4M shares for resale amid ongoing losses and high debt.MSPR
Registration Filing29 Nov 2025 - Severe revenue decline, mounting losses, and delisting risk threaten ongoing operations.MSPR
Q3 202519 Nov 2025 - Severe losses, minimal revenue, and urgent liquidity risks threaten ongoing operations.MSPR
Q2 202514 Aug 2025